---
document_datetime: 2025-11-23 08:02:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/posaconazole-sp.html
document_name: posaconazole-sp.html
version: success
processing_time: 0.0979028
conversion_datetime: 2025-12-27 15:41:21.617506
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Posaconazole SP

[RSS](/en/individual-human-medicine.xml/65508)

##### Lapsed

This medicine's authorisation has lapsed

posaconazole

Medicine

Human

Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 25 October 2005, the European Commission granted a marketing authorisation valid throughout the European Union (EU) for the medicinal product Posaconazole SP (posaconazole), indicated for use in the treatment of fungal infections in adults (invasive aspergillosis, fusariosis, chromoblastomycosis and mycetoma, coccidioidomycosis and oropharyngeal candidiasis), and for prophylaxis of invasive fungal infections in patients receiving remission-induction chemotherapy for acute myelogenous leukemia or myelodysplastic syndromes, and in hematopoietic stem cell transplant.

Posaconazole SP (posaconazole) had not been marketed in Europe since this initial marketing authorisation. In accordance with article 14(4) of Regulation (EC) No 726/2004 ('sunset clause'), the marketing authorisation of a medicinal product lapses if the product has never been marketed in one of the Member States within three years of its initial authorisation, calculated from the entry into force of the Regulation (20 November 2005) for products authorised before this date. Because of this, from 20 November 2008, the marketing authorisation for Posaconazole SP is no longer valid. Noxafil (posaconazole) is an identical product authorised in the EU.

Pursuant to the expiry of the marketing authorisation, the European Assessment Report (EPAR) for Posaconazole SP is updated to reflect that the marketing authorisation is no longer valid.

Posaconazole SP : EPAR - Summary for the public

English (EN) (259.52 KB - PDF)

**First published:** 31/07/2009

**Last updated:** 31/07/2009

[View](/en/documents/overview/posaconazole-sp-epar-summary-public_en.pdf)

[Other languages (20)](#file-language-dropdown-560)

български (BG) (446.11 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/bg/documents/overview/posaconazole-sp-epar-summary-public_bg.pdf)

español (ES) (261.74 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/es/documents/overview/posaconazole-sp-epar-summary-public_es.pdf)

čeština (CS) (408 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/cs/documents/overview/posaconazole-sp-epar-summary-public_cs.pdf)

dansk (DA) (305.88 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/da/documents/overview/posaconazole-sp-epar-summary-public_da.pdf)

Deutsch (DE) (264.21 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/de/documents/overview/posaconazole-sp-epar-summary-public_de.pdf)

eesti keel (ET) (260.22 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/et/documents/overview/posaconazole-sp-epar-summary-public_et.pdf)

ελληνικά (EL) (455.69 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/el/documents/overview/posaconazole-sp-epar-summary-public_el.pdf)

français (FR) (263.67 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/fr/documents/overview/posaconazole-sp-epar-summary-public_fr.pdf)

italiano (IT) (262.22 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/it/documents/overview/posaconazole-sp-epar-summary-public_it.pdf)

latviešu valoda (LV) (411.76 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/lv/documents/overview/posaconazole-sp-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (383.61 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/lt/documents/overview/posaconazole-sp-epar-summary-public_lt.pdf)

magyar (HU) (398.19 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/hu/documents/overview/posaconazole-sp-epar-summary-public_hu.pdf)

Nederlands (NL) (262.66 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/nl/documents/overview/posaconazole-sp-epar-summary-public_nl.pdf)

polski (PL) (416.11 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/pl/documents/overview/posaconazole-sp-epar-summary-public_pl.pdf)

português (PT) (262.1 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/pt/documents/overview/posaconazole-sp-epar-summary-public_pt.pdf)

română (RO) (378.75 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/ro/documents/overview/posaconazole-sp-epar-summary-public_ro.pdf)

slovenčina (SK) (404.48 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sk/documents/overview/posaconazole-sp-epar-summary-public_sk.pdf)

slovenščina (SL) (390.38 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sl/documents/overview/posaconazole-sp-epar-summary-public_sl.pdf)

Suomi (FI) (261.04 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/fi/documents/overview/posaconazole-sp-epar-summary-public_fi.pdf)

svenska (SV) (256.68 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sv/documents/overview/posaconazole-sp-epar-summary-public_sv.pdf)

## Product information

Posaconazole SP : EPAR - Product Information

English (EN) (935.2 KB - PDF)

**First published:** 31/07/2009

**Last updated:** 31/07/2009

[View](/en/documents/product-information/posaconazole-sp-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-804)

български (BG) (897.89 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/bg/documents/product-information/posaconazole-sp-epar-product-information_bg.pdf)

español (ES) (632.89 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/es/documents/product-information/posaconazole-sp-epar-product-information_es.pdf)

čeština (CS) (775.15 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/cs/documents/product-information/posaconazole-sp-epar-product-information_cs.pdf)

dansk (DA) (655.97 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/da/documents/product-information/posaconazole-sp-epar-product-information_da.pdf)

Deutsch (DE) (675.08 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/de/documents/product-information/posaconazole-sp-epar-product-information_de.pdf)

eesti keel (ET) (652.13 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/et/documents/product-information/posaconazole-sp-epar-product-information_et.pdf)

ελληνικά (EL) (907.21 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/el/documents/product-information/posaconazole-sp-epar-product-information_el.pdf)

français (FR) (671.14 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/fr/documents/product-information/posaconazole-sp-epar-product-information_fr.pdf)

italiano (IT) (626.22 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/it/documents/product-information/posaconazole-sp-epar-product-information_it.pdf)

latviešu valoda (LV) (821.71 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/lv/documents/product-information/posaconazole-sp-epar-product-information_lv.pdf)

lietuvių kalba (LT) (729.29 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/lt/documents/product-information/posaconazole-sp-epar-product-information_lt.pdf)

magyar (HU) (742.8 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/hu/documents/product-information/posaconazole-sp-epar-product-information_hu.pdf)

Malti (MT) (754.54 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/mt/documents/product-information/posaconazole-sp-epar-product-information_mt.pdf)

Nederlands (NL) (667.94 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/nl/documents/product-information/posaconazole-sp-epar-product-information_nl.pdf)

polski (PL) (825.61 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/pl/documents/product-information/posaconazole-sp-epar-product-information_pl.pdf)

português (PT) (641.04 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/pt/documents/product-information/posaconazole-sp-epar-product-information_pt.pdf)

română (RO) (720.32 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/ro/documents/product-information/posaconazole-sp-epar-product-information_ro.pdf)

slovenčina (SK) (767.33 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sk/documents/product-information/posaconazole-sp-epar-product-information_sk.pdf)

slovenščina (SL) (727.39 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sl/documents/product-information/posaconazole-sp-epar-product-information_sl.pdf)

Suomi (FI) (646.46 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/fi/documents/product-information/posaconazole-sp-epar-product-information_fi.pdf)

svenska (SV) (616.42 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sv/documents/product-information/posaconazole-sp-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0011 04/12/2008

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Posaconazole SP : EPAR - All Authorised presentations

English (EN) (18.75 KB - PDF)

**First published:** 31/07/2009

**Last updated:** 31/07/2009

[View](/en/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_en.pdf)

[Other languages (18)](#file-language-dropdown-995)

español (ES) (20.03 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/es/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_es.pdf)

čeština (CS) (81.17 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/cs/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (21.59 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/da/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (19.03 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/de/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (17.29 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/et/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (86.07 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/el/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_el.pdf)

français (FR) (18.85 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/fr/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (16.73 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/it/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (81.51 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/lv/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (85.1 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/lt/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (60 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/hu/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_hu.pdf)

Nederlands (NL) (19.84 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/nl/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_nl.pdf)

polski (PL) (90.93 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/pl/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_pl.pdf)

português (PT) (18.37 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/pt/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_pt.pdf)

slovenčina (SK) (83.57 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sk/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (81.59 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sl/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (20.55 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/fi/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (23.16 KB - PDF)

**First published:**

31/07/2009

**Last updated:**

31/07/2009

[View](/sv/documents/all-authorised-presentations/posaconazole-sp-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Posaconazole SP Active substance posaconazole International non-proprietary name (INN) or common name posaconazole Therapeutic area (MeSH)

- Candidiasis
- Mycoses
- Coccidioidomycosis
- Aspergillosis

Anatomical therapeutic chemical (ATC) code J02AC04

### Pharmacotherapeutic group

Antimycotics for systemic use

### Therapeutic indication

Posaconazole SP is indicated for use in the treatment of the following fungal infections in adults (see section 5.1):

## Authorisation details

EMA product number EMEA/H/C/000611 Marketing authorisation holder

Schering-Plough Europe

SP Europe Rue de Stalle, 73 B-1180 Bruxelles Belgium

Marketing authorisation issued 25/10/2005 Lapse of marketing authorisation 20/11/2008 Revision 5

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Posaconazole SP : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (57.47 KB - PDF)

**First published:** 31/07/2009

**Last updated:** 31/07/2009

[View](/en/documents/procedural-steps-after/posaconazole-sp-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Posaconazole SP-H-C-611-II-02 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (514.23 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/scientific-discussion-variation/posaconazole-sp-h-c-611-ii-02-epar-scientific-discussion-variation_en.pdf)

Posaconazole SP-H-C-611-II-01 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (466.42 KB - PDF)

**First published:** 04/08/2009

**Last updated:** 04/08/2009

[View](/en/documents/scientific-discussion-variation/posaconazole-sp-h-c-611-ii-01-epar-scientific-discussion-variation_en.pdf)

## Initial marketing authorisation documents

Posaconazole SP : EPAR - Procedural steps taken before authorisation

English (EN) (28.28 KB - PDF)

**First published:** 31/07/2009

**Last updated:** 31/07/2009

[View](/en/documents/procedural-steps/posaconazole-sp-epar-procedural-steps-taken-authorisation_en.pdf)

Posaconazole SP : EPAR - Scientific Discussion

English (EN) (617.65 KB - PDF)

**First published:** 31/07/2009

**Last updated:** 31/07/2009

[View](/en/documents/scientific-discussion/posaconazole-sp-epar-scientific-discussion_en.pdf)

**This page was last updated on** 04/08/2009

## Share this page

[Back to top](#main-content)